Tax Reform Code of 1971 (TRC)

The Tax Reform Code of 1971 is Pennsylvania’s primary legislative vehicle for state taxation, providing the statutory basis for the Research and Development Tax Credit which incentivizes businesses to increase innovation expenditures within the Commonwealth. By offering a credit against corporate and personal income taxes for qualified research conducted specifically in Pennsylvania, the code transforms tax liability into a strategic investment tool for technological advancement.

The Historical and Legal Genesis of the Tax Reform Code of 1971

The Tax Reform Code of 1971, officially designated as Act 2 of 1971, was established during a period of intense fiscal restructuring in Pennsylvania. Its primary purpose was to consolidate various disparate taxing statutes into a single, cohesive framework that could be managed by the newly empowered Department of Revenue. At its inception, the code focused heavily on the imposition of the Sales and Use Tax (Article II), the Personal Income Tax (Article III), and the Corporate Net Income Tax (Article IV). These articles established the “qualified tax liabilities” against which future credits, such as the Research and Development (R&D) credit, would eventually be applied.

The evolution of the Code from a pure revenue-collection instrument to an economic development tool began in earnest in the late 1990s. As the national economy shifted toward technology and high-value services, the Pennsylvania General Assembly recognized the need to provide competitive fiscal incentives to retain and attract knowledge-based industries. This realization led to the enactment of Act 7 of 1997, which added Article XVII-B to the Tax Reform Code, formally creating the Research and Development Tax Credit Law. The inclusion of this article within the TRC was a deliberate choice, ensuring that the credit would be deeply integrated with the existing definitions of income, apportionment, and taxpayer entity types already codified in Articles III and IV.

The meaning of the TRC in the context of R&D is therefore one of integration; it represents the convergence of traditional tax administration with modern industrial policy. The Code provides the “playing field”—the definitions of taxpayers, gross receipts, and taxable income—while Article XVII-B provides the “rules of the game” for innovation-specific incentives. This structural synergy allows the Commonwealth to target specific economic behaviors, such as increasing year-over-year research spending, while utilizing the established enforcement and audit mechanisms of the Department of Revenue.

Structural Architecture of Article XVII-B: Statutory Analysis

The Research and Development Tax Credit Law is organized into several key sections within Article XVII-B, each serving a distinct regulatory function. To understand the law’s application, one must parse the language of Sections 1701-B through 1713-B, which define the scope of the credit, the eligibility of taxpayers, and the administrative powers of the Department.

Section 1701-B and 1702-B: Definitions and Scope

Section 1701-B establishes the short title, while Section 1702-B provides the definitions that are the bedrock of the program. A “taxpayer” is defined broadly as an entity subject to tax under Article III (Personal Income Tax), Article IV (Corporate Net Income Tax), or Article VI (Capital Stock and Franchise Tax, though the latter has been phased out). Crucially, this definition includes shareholders of Pennsylvania S corporations, ensuring that the benefit of the credit can flow through to individual owners of pass-through entities.

The definition of “Gross Receipts” in Section 1702-B is particularly nuanced. It specifies that gross receipts consist only of those effectively connected with the conduct of a trade or business within Pennsylvania. This determination is made by reference to Section 401 of the TRC, which governs how corporate income is apportioned to the state. This ensures that the credit is grounded in actual Pennsylvania economic activity rather than global corporate volume. Furthermore, “Pennsylvania qualified research and development” is explicitly limited to research and development conducted within the Commonwealth, a geographic restriction that distinguishes the state credit from its federal counterpart.

Section 1703-B: The Mechanism of the Credit

Section 1703-B authorizes the credit itself. It provides that a taxpayer who incurs Pennsylvania qualified research and development expense (PQRE) may apply for the credit. The law establishes a dual-rate system based on the size of the business. Small businesses, defined as for-profit entities with a net book value of assets totaling less than $5 million at the beginning or end of the year, are entitled to a credit of 20% of the excess of their PQRE over their Pennsylvania base amount. All other taxpayers receive a 10% credit on that same excess.

This differentiation is a core policy feature of the TRC. It acknowledges that smaller firms often face higher relative costs for innovation and lack the immediate tax liability to fully utilize credits, thus requiring a more potent incentive to reach economic parity with larger competitors. The base amount calculation—using the taxpayer’s historical spending or 50% of current year expenses—ensures that the Commonwealth is rewarding growth in R&D, not just sustaining current levels.

Statutory Provision	Section Reference	Primary Legal Function
Short Title	§ 1701-B	Identifies the Research and Development Tax Credit Law.
Definitions	§ 1702-B	Codifies “Small Business,” “PQRE,” and “PA Base Amount.”
Credit Authorization	§ 1703-B	Sets the 10%/20% rates and the application requirement.
Transferability	§ 1704-B	Governs carryovers, sales, and assignments of credits.
IRC Conformity	§ 1705-B	Adopts federal Section 41 standards for research quality.
Time Limitations	§ 1707-B	Establishes application and notification deadlines.
Cap on Credits	§ 1709-B	Limits total annual awards (currently $60 million).

Local State Revenue Office Guidance: The Administrative Framework

While the TRC provides the legal mandate, the Pennsylvania Department of Revenue (DOR) provides the operational guidance that dictates how taxpayers interact with the law. This guidance is issued through various channels, including Informational Notices, Tax Bulletins, and the myPATH online portal documentation.

The myPATH Ecosystem and Filing Requirements

The transition to myPATH as the primary interface for tax credit applications represents a significant shift in DOR guidance. Taxpayers are no longer permitted to file paper applications; all submissions must be completed through the logged-in myPATH system between August 1 and December 1 of each year. The DOR provides video tutorials and specific “myPATH Send a Message” subtypes for R&D questions, effectively creating a direct digital line between the taxpayer and the Bureau of Research.

DOR guidance emphasizes the necessity of a “tax clearance” before any credit can be awarded. Under Act 43 of 2017, the Department will not approve an R&D credit for any applicant—or any owner with a 20% or greater stake—who is non-compliant with other state tax obligations. This means that a minor delinquency in sales tax or employer withholding can disqualify a multimillion-dollar R&D credit application, a point of guidance that is strictly enforced.

Project Documentation and the Four-Part Test

A critical piece of DOR guidance involves the “Project Description” section of the application. The Department requires detailed responses to four specific questions designed to verify that the research meets the federal IRC Section 41(d) standards as adopted by the TRC. The narrative must explicitly address:

1. Elimination of Uncertainty: The applicant must describe the technical challenges faced and why the solution was not readily available or apparent at the project’s outset.
2. Process of Experimentation: Guidance requires a description of the methods used, such as modeling, simulation, or systematic trial-and-error, to evaluate alternatives.
3. Technological in Nature: The research must be shown to rely on “hard sciences” like engineering, physics, or computer science.
4. Qualified Purpose: The project must aim to improve the function, performance, or reliability of a business component.

DOR guidance warns that “improperly classifying subcontractor expenditures as direct wages” is a common error that leads to application rejection. Subcontractor costs must be reported separately, including the FEIN and the amount paid, as they are generally only includable at 65% of their value under federal guidelines adopted by the state.

The Meaning of “Qualified Research” in the Pennsylvania Context

The TRC’s adoption of the federal definition of “qualified research” is a strategic move that provides a measure of predictability for taxpayers who already claim the federal R&D credit under IRC Section 41. However, the meaning of “qualified research” in Pennsylvania is more restrictive in its geographic application.

Inclusions and Exclusions

Qualified research in Pennsylvania typically includes software development, manufacturing process optimization, and the design of new prototypes. For instance, a software company developing a new AI-driven donation platform or a manufacturer engineering advanced robotics for industrial automation would likely meet the criteria. Conversely, activities such as routine data collection, market research, or social science research are generally excluded.

A significant area of recent guidance concerns the location of the research. As the workforce has become more distributed, the meaning of “conducted in this Commonwealth” has come under closer scrutiny. Current DOR interpretation requires that the R&D activities—the actual experimentation and technical work—occur within Pennsylvania’s borders. If a Pennsylvania-based company employs remote engineers living in other states, the wages paid to those engineers generally cannot be included in the PQRE calculation, even if the project is managed from a Pennsylvania headquarters.

The Role of IRC Section 174

The interaction between the TRC and IRC Section 174 has become a focal point of state revenue guidance following federal changes in 2022. The federal government began requiring the amortization of R&D expenses over five years rather than allowing immediate expensing. In response, Pennsylvania enacted Act 45 of 2025 to “decouple” the state tax from this federal change. This means that for Pennsylvania purposes, businesses can still claim an additional deduction for R&E expenditures to offset the federal amortization requirement, effectively restoring the immediate tax benefit of innovation at the state level.

Calculation Methodology: The Pennsylvania Base Amount

The calculation of the Pennsylvania R&D tax credit is a multi-step process that relies on the “incremental” model. This model is designed to reward companies that are actively growing their research footprint in the state.

Mathematical Foundation

The fundamental formula for the credit is based on the excess of current year PQRE over a historical baseline. The TRC defines the “Pennsylvania base amount” with reference to IRC Section 41(c), modified for state-specific research. The base amount is calculated as the greater of two figures to prevent the credit from being excessively volatile or rewarding incidental spending:

1. The Prior Year Average: The average of the taxpayer’s PQRE over the four preceding taxable years.
2. The 50% Floor: 50% of the current year’s PQRE.

For a large business, the credit is 10% of the difference. For a small business, it is 20%.

$$Credit_{Large} = 0.10 \times (PQRE_{Current} – Base Amount)$$

$$Credit_{Small} = 0.20 \times (PQRE_{Current} – Base Amount)$$

The Proration Effect

While the formula provides a “tentative” credit, the actual credit received is often lower due to the statewide cap. The TRC mandates that the total credits awarded each year cannot exceed a set limit—currently $60 million. If the total tentative credits for all qualified applicants exceed this amount, the Department of Revenue must prorate the awards.

DOR reports reveal that the small business set-aside of $12 million is frequently sufficient to cover 100% of small business requests. However, the large business portion is typically oversubscribed. For example, in the 2024 award cycle, large businesses received only approximately 41.1% of their tentative credit amounts. This means the “effective” credit rate for a large business might be closer to 4.1% rather than the statutory 10%.

Financial Year	Total Cap	Small Biz Set-Aside	Large Biz Proration %	Small Biz Proration %
2022-23	$60,000,000	$12,000,000	~40-45%	100%
2023-24	$60,000,000	$12,000,000	41.1%	100%

Small Business vs. Large Business: Asset-Based Classification

The distinction between a small and large business under the TRC is based solely on the net book value of assets, not on revenue or employee count. This is a critical distinction in Pennsylvania law that often surprises taxpayers accustomed to federal SBA standards.

Asset Valuation and the $5 Million Threshold

A small business is defined as an entity with a net book value of assets totaling less than $5 million at either the beginning or the end of the taxable year for which the credit is claimed. The DOR requires the submission of a balance sheet to substantiate this claim. “Net book value” generally refers to the historical cost of the assets minus accumulated depreciation, as reported for financial accounting purposes.

This asset-based definition can create strategic opportunities and challenges. For example, a high-revenue software company with few physical assets may qualify as a “small business” and receive a 20% credit, while a capital-intensive manufacturing startup with significant machinery might exceed the $5 million threshold and be restricted to the 10% rate. The “beginning or end of the year” provision allows some flexibility for growing firms that cross the threshold mid-year.

Policy Implications of the Set-Aside

The $12 million set-aside for small businesses represents 20% of the total R&D credit pool. This carve-out is a direct result of legislative advocacy intended to ensure that early-stage technology firms are not crowded out by massive multinational corporations. In award year 2023 (distributed May 2024), 198 small business applicants benefited from this set-aside, receiving 100% of their tentative requests. This high approval rate makes the Pennsylvania credit one of the most reliable incentives for the state’s startup ecosystem.

The Monetization of Credits: Sale, Assignment, and Pass-Through

A defining feature of the Pennsylvania TRC is the ability for taxpayers to monetize their credits. This is particularly valuable for “pre-revenue” or low-profit innovation firms that have significant R&D expenses but little to no state tax liability to offset.

The Assignment Program and the DCED

Under Act 46 of 2003 and subsequent amendments, taxpayers may apply to the Department of Community and Economic Development (DCED) to sell or assign their unused R&D credits. The “seller” must have been awarded the credit by the DOR and must demonstrate that they have not used the credit against their own liability.

The market for these credits is well-established, with credits typically selling for 85 to 95 cents on the dollar. The purchaser can then use the credit to offset up to 75% of their own qualified tax liability in the year of the purchase. Buyers are prohibited from carrying the purchased credit forward, carrying it back, or reselling it, making the “use it or lose it” rule a central piece of guidance for credit brokers.

Pass-Through Entity Dynamics

For S corporations, partnerships, and LLCs treated as partnerships, the credit is typically passed through to the owners based on their proportional ownership. Section 1710-B of the TRC specifically governs these pass-through mechanics. Owners claim their share of the credit on their PA-40 personal income tax return using Schedule OC.

The DOR provides specific guidance for these entities via Form REV-1123, which allows a business to make an irrevocable election to pass the credit through to its partners or shareholders. This flexibility allows individual investors in Pennsylvania startups to directly reduce their personal income tax burden, further incentivizing private investment in the state’s technology sector.

Compliance, Oversight, and the 2019 Grand Jury Findings

The integrity of the R&D tax credit program is maintained through rigorous oversight. The DOR is empowered to conduct onsite audits and request additional documentation to verify that the research activities actually occurred in Pennsylvania.

Lessons from the Grand Jury Investigation

A 2019 Grand Jury report exposed systemic attempts to defraud the R&D credit program, where entities with no actual research activity filed fraudulent applications for millions of dollars in credits. In response, the DOR tightened its compliance standards, including the mandatory tax clearance for all owners and more stringent narrative requirements in the application. The report highlighted that fraudulent claims directly harm legitimate innovators by diluting the available pool of credits through proration.

Documentation Retention and Appeals

Taxpayers are advised by the DOR to maintain robust project tracking systems and detailed records of technical challenges, testing results, and personnel time allocation for a period of five years. If an application is rejected or the credit amount is disputed, Act 25 of 2021 provides a formal appeals process. Taxpayers have the right to appeal DOR determinations to the Board of Appeals, a relatively new right that was first fully implemented for the 2021 application year.

Legislative Evolution: 1997 to 2025

The R&D tax credit has been shaped by a series of legislative acts that have expanded its scope and refined its administration. Understanding this chronology is essential for interpreting the current state of the TRC.

Act Number	Year	Key Modification to R&D Credit
Act 7	1997	Established Article XVII-B and the R&D credit program.
Act 46	2003	Created the sale and assignment program for unused credits.
Act 116	2006	Increased the small business credit rate to 20%.
Act 48	2009	Removed the one-year holding period for the sale of credits.
Act 85	2016	Repealed the sunset provision, making the credit permanent.
Act 43	2017	Mandated tax clearance for all applicants.
Act 25	2021	Moved application deadline to Dec 1 and created appeals process.
Act 53	2022	Increased the annual cap to $60 million.
Act 45	2025	Decoupled PA from federal IRC 174 amortization rules.

These changes reflect a consistent bipartisan trend toward supporting the credit. The increase in the cap from $15 million in 1997 to $60 million today demonstrates the program’s perceived value in the Commonwealth’s economic development portfolio.

Example: Precision Medical Engineering, Inc.

To illustrate the complex interplay of the TRC, DOR guidance, and the R&D credit, we examine the hypothetical case of “Precision Medical Engineering, Inc.” (PME), a C-corporation located in the Lehigh Valley, Pennsylvania.

Year 1: Startup and Credit Generation

PME was founded in 2022 to develop a new type of laser-etched cardiac stent. In its first two years, PME incurred significant research costs. For the 2023 tax year, PME reports the following:

• Net Book Value of Assets: $2,400,000 (qualifying it as a “Small Business”).
• PA Qualified Research Expenses (PQRE): $1,200,000 in direct wages for PA engineers and $300,000 in supplies.
• Historical Average: As a new company, its 4-year average is low ($400,000).

Calculation:

The base amount is the greater of the 4-year average ($400,000) or 50% of current PQRE ($750,000). Thus, the base amount is $750,000.

The tentative credit is 20% of the excess: $0.20 \times (\$1,500,000 – \$750,000) = \mathbf{\$150,000}$.

Year 2: Compliance and Filing

PME registers for a myPATH account and submits its application by December 1, 2024. It includes its federal Form 6765 and a detailed narrative explaining how it used trial-and-error modeling to eliminate uncertainty in the stent’s laser-etching process. The DOR performs a tax clearance. PME discovers it has a small $500 outstanding penalty for a late-filed payroll report from 2023. Per DOR guidance, PME must pay this immediately to clear its status.

By May 1, 2025, PME receives an award letter from the DOR for the full $150,000, as small business requests did not exceed the $12 million set-aside.

Year 3: Monetization for Cash Flow

PME is still in the clinical trial phase and has zero tax liability for the year. It does not want to wait 15 years to carry the credit forward. PME applies to the DCED to sell its $150,000 credit.

A local banking conglomerate with a high PA tax liability agrees to buy the credit at 92 cents on the dollar.

• PME (Seller) receives: $\$150,000 \times 0.92 = \mathbf{\$138,000}$ in immediate cash.
• Bank (Buyer) receives: A $150,000 credit to apply against its 2025 Corporate Net Income Tax, limited to 75% of its total liability.

The $138,000 received by PME is a taxable transaction, which PME reports on its next tax return, but the cash provides critical funding for its next round of R&D.

Comparative Analysis: Pennsylvania vs. National Trends

Pennsylvania’s R&D credit, governed by the TRC, is modeled after the federal “Credit for Increasing Research Activities” established in 1981, but it possesses unique state-level characteristics.

While most states offer some form of R&D credit, Pennsylvania’s $60 million cap is relatively large, though it trails states like New York, which offers a $250 million cap for its program. However, Pennsylvania’s transferability feature—the ability to sell credits—is a distinguishing factor that makes it more competitive for startups than states like Minnesota or Arizona, which have more restrictive refundability or carryforward rules.

State	Credit Rate (Regular)	Small Business Benefit	Transferability
Pennsylvania	10%	20% Rate	Yes (Sale/Assignment)
California	15%	N/A	No
New Jersey	10%	N/A	Restricted
Minnesota	10% (on first $2M)	N/A	No

This comparative advantage highlights the “meaning” of the TRC as a flexible and market-oriented statute. By allowing credits to be treated as a tradable asset, the Commonwealth effectively leverages the tax liabilities of its most profitable companies to finance the R&D of its newest innovators.

Final Thoughts

The Research and Development Tax Credit, as codified in Article XVII-B of the Tax Reform Code of 1971, is more than a simple tax break; it is a sophisticated mechanism of industrial policy designed to foster a high-tech ecosystem within Pennsylvania. The meaning of the TRC in this context is defined by three core pillars: geographic exclusivity, incremental rewards for growth, and financial liquidity through transferability.

For professional peers and tax practitioners, the complexity of the TRC requires a meticulous approach to compliance. The Department of Revenue’s shift toward the myPATH digital portal and the mandatory tax clearance protocols under Act 43 mean that operational excellence is just as important as technical research quality in securing these credits. Furthermore, the recent legislative move to decouple from federal IRC 174 amortization through Act 45 of 2025 underscores the Commonwealth’s commitment to shielding its innovation sector from adverse federal tax shifts.

Looking forward, the permanent nature of the credit and the fixed $60 million cap through June 2025 provide a stable horizon for corporate planning. However, as the total volume of qualified research in Pennsylvania continues to grow, the proration of credits for large businesses will likely increase, further highlighting the strategic value of the small business set-aside. For any entity conducting technical work in Pennsylvania, from software development to advanced manufacturing, the TRC remains the single most important legal framework for capturing the value of their intellectual investment.